Observational studyFrontiers in immunology2022

Cellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine - A Prospective Observational Study.

Jonas Herzberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.